Before a solution reaches millions, we need to know that it works.
With a rigorous methodology for testing and iterating on our solutions, we are continually learning and improving our solutions to bring evidence-based innovation to every area of health care. In the Test phase of the Arc, we ensure that we’ve designed an effective, scalable solution.
Precision Population Health and Corewell Health Pilot Genomic Screening in Primary Health Care
Precision Population Health and Michigan-based Corewell Health launched a pilot program to offer genetic screening to 1,000 primary care patients. The screening tests for up to 167 genes, each of which can provide actionable information to help clinicians and patients detect disease early or prevent it altogether. The Ariadne Labs team has created implementation resources, conversations guides, clinician tools, and more to help bring this screening to primary care practices. In the next phase of the project, the team will continue to iterate on the clinical pathway for scaling the program.
In October 2022, Precision Population Health co-hosted the inaugural International Conference on Newborn Sequencing (ICoNS) in Boston, MA. The first-of-its-kind event drew more than 500 leading researchers and clinicians from around the world to share opportunities and challenges of genetic sequencing for newborns. A second conference is planned for October 2023 in London, co-hosted with Genomics England.
Safe Surgery/Safe Systems Partnership Re-Implements Checklist at Singapore General Hospital
The Safe Surgery/Safe Systems team partnered with Singapore General Hospital (SGH) and Johnson & Johnson to evaluate, modify, and re-implement SGH’s WHO Surgical Safety Checklist. As part of the re-implementation, the team incorporated the Device Briefing Tool, an innovative new tool developed in partnership with Johnson & Johnson and designed to meet the safety challenges posed by the ever-increasing number of new and complex surgical devices used in operating rooms.
Findings from this work demonstrated the utility of the Device Briefing Tool, with fewer safety issues related to device use, and the tool’s high acceptability, with both surgeons and nurses rating it as highly useful. The work yielded key insights on the importance of health facilities, even high-performing ones, periodically re-visiting their Checklist to ensure it is being used consistently and meeting the current challenges and demands of the operating room. Re-visiting Checklist implementation also offers an opportunity to capitalize on its use a vehicle to introduce innovative new safety measures.
Home Hospital Tests New Methodologies, Tools, and Models
The Home Hospital Early Adopters Accelerator, led by Ariadne Labs and CaroNova, brought together 18 health organizations in the U.S., Canada, and South Africa to develop the tools health systems need to launch and sustain their own home hospital programs. In just 32 weeks, accelerator participants used the Scrum framework to produce 20 knowledge products, including clinical protocols, administrative workflows, and patient-facing tools. Work is currently underway to evaluate uptake of the products after one year.
Home Hospital also launched patient enrollment for the first-ever international randomized controlled trial of a Rural Home Hospital model. By the end of 2022, the trial had successfully enrolled 15% of its total patients across three sites in the U.S. and Canada, and 64 providers had completed remote training on the model.